Mifepristone and misoprostol for early abortion when no gestational sac is present
- PMID: 11448464
- DOI: 10.1016/s0010-7824(01)00200-1
Mifepristone and misoprostol for early abortion when no gestational sac is present
Abstract
The study was conducted to determine whether the administration of mifepristone followed by vaginal misoprostol can induce an abortion in early pregnancy when no gestational sac is present on sonogram. This report presents a prospective, pilot study of 30 healthy adult women, pregnant and seeking an abortion, and with no gestational sac on sonogram. All women had a baseline serum chorionic gonadotropin (hCG) level measured prior to using mifepristone 200 mg orally followed by misoprostol 800 mcg vaginally 48 h later, and then returned up to 4 days later for a repeat sonogram and serum hCG level. Women with initial hCG levels > 2000 IU/L were evaluated for ectopic pregnancy. At the first follow-up visit, if the hCG decreased by >50%, the women were followed with home pregnancy (25 IU/L) tests weekly until negative. If the levels did not decrease by 50%, a second dose of misoprostol was given. Surgical intervention was indicated for persistent hCG levels or excessive bleeding. Of the 30 women enrolled, the mean number of days of amenorrhea was 40 (SD 9) days. Two women had surgical intervention for continuing pregnancy, 2 had ectopic pregnancies, and 1 was lost to follow-up. Complete medical abortions occurred in 25/30 (88%) women, but when recalculated, in 25/27 (93%) women who completed the protocol and who did not have an ectopic pregnancy. There was 1 adverse event in a woman with an ongoing pregnancy who then received methotrexate. She was hospitalized a day later with a complicated pelvic infection and likely methotrexate-induced pneumonitis. Twenty-three women had a decrease in hCG at first follow-up visit of >50%. All 27 women who completed the protocol found the overall regimen acceptable. Mifepristone followed at 48 h by vaginal misoprostol were effective and acceptable in inducing an abortion in very early pregnancy. There may be a higher incidence of failure in very early pregnancies. Documentation of a complete abortion by hCG level is necessary to ensure the pregnancy is neither ongoing nor ectopic.
Similar articles
-
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.Contraception. 1999 Jan;59(1):1-6. doi: 10.1016/s0010-7824(98)00150-4. Contraception. 1999. PMID: 10342079 Clinical Trial.
-
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.Contraception. 2000 Jan;61(1):41-6. doi: 10.1016/s0010-7824(99)00119-5. Contraception. 2000. PMID: 10745068 Clinical Trial.
-
Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.Contraception. 2001 Aug;64(2):81-5. doi: 10.1016/s0010-7824(01)00229-3. Contraception. 2001. PMID: 11704083 Clinical Trial.
-
Early pregnancy loss medical management in clinical practice.Contraception. 2023 Oct;126:110134. doi: 10.1016/j.contraception.2023.110134. Epub 2023 Jul 29. Contraception. 2023. PMID: 37524147 Review.
-
Early medical abortion.Best Pract Res Clin Obstet Gynaecol. 2025 Mar;99:102588. doi: 10.1016/j.bpobgyn.2025.102588. Epub 2025 Feb 21. Best Pract Res Clin Obstet Gynaecol. 2025. PMID: 40015183 Review.
Cited by
-
Unexpected heaping in reported gestational age for women undergoing medical abortion.Contraception. 2009 Sep;80(3):287-91. doi: 10.1016/j.contraception.2009.03.008. Epub 2009 May 9. Contraception. 2009. PMID: 19698823 Free PMC article.
-
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16. Contraception. 2020. PMID: 32305289 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical